Literature DB >> 24367206

Implications for breast cancer dormancy in other areas of medicine.

Pranela Rameshwar1.   

Abstract

Entities:  

Year:  2012        PMID： 24367206      PMCID： PMC3846419          DOI： 10.2147/BCTT.S36779

Source DB:  PubMed          Journal:  Breast Cancer (Dove Med Press)        ISSN： 1179-1314


× No keyword cloud information.
  8 in total

1.  AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cells.

Authors:  Steven J Greco; Shyam A Patel; Margarette Bryan; Lillian F Pliner; Debabrata Banerjee; Pranela Rameshwar
Journal:  Am J Cancer Res       Date:  2011-06-25       Impact factor: 6.166

2.  Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers.

Authors:  Giulia Grisendi; Rita Bussolari; Elena Veronesi; Serena Piccinno; Jorge S Burns; Giorgio De Santis; Pietro Loschi; Marco Pignatti; Fabrizio Di Benedetto; Roberto Ballarin; Carmela Di Gregorio; Valentina Guarneri; Lino Piccinini; Edwin M Horwitz; Paolo Paolucci; Pierfranco Conte; Massimo Dominici
Journal:  Am J Cancer Res       Date:  2011-05-28       Impact factor: 6.166

3.  Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta.

Authors:  Shyam A Patel; Justin R Meyer; Steven J Greco; Kelly E Corcoran; Margarette Bryan; Pranela Rameshwar
Journal:  J Immunol       Date:  2010-04-09       Impact factor: 5.422

4.  Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells.

Authors:  Philip K Lim; Sarah A Bliss; Shyam A Patel; Marcelo Taborga; Meneka A Dave; Larissa A Gregory; Steven J Greco; Margarette Bryan; Prem S Patel; Pranela Rameshwar
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

5.  Molecular targeting of malignant glioma cells with an EphA2-specific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells.

Authors:  Xin-Lin Sun; Zhi-Min Xu; Yi-Quan Ke; Chang-Chen Hu; Shi-Yong Wang; Geng-Qiang Ling; Zhong-Jie Yan; Yi-Jing Liu; Zhen-Hua Song; Xiao-Dan Jiang; Ru-Xiang Xu
Journal:  Cancer Lett       Date:  2011-08-17       Impact factor: 8.679

Review 6.  Significance and mechanism of lymph node metastasis in cancer progression.

Authors:  Kenji Kawada; Makoto M Taketo
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

Review 7.  Dormancy in breast cancer.

Authors:  Malgorzata Banys; Andreas D Hartkopf; Natalia Krawczyk; Tatjana Kaiser; Franziska Meier-Stiegen; Tanja Fehm; Hans Neubauer
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-12-05

Review 8.  The prognostic impact of bone marrow micrometastases in women with breast cancer.

Authors:  Stephan Braun; Doris Auer; Christian Marth
Journal:  Cancer Invest       Date:  2009-07       Impact factor: 2.176
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.